Aldeyra Therapeutics, Inc.
ALDX
$2.76
$0.103.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.85M | -44.80M | -37.87M | -30.01M | -37.54M |
| Total Depreciation and Amortization | 249.60K | 251.70K | 253.70K | 256.40K | 262.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.48M | 4.91M | 3.04M | 3.26M | 6.09M |
| Change in Net Operating Assets | 5.91M | 8.96M | 3.86M | -4.37M | 861.10K |
| Cash from Operations | -43.21M | -30.67M | -30.72M | -30.86M | -30.33M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.92M | -43.35M | -48.61M | -30.38M | 30.00M |
| Cash from Investing | -44.92M | -43.35M | -48.61M | -30.38M | 30.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -292.50K | -1.04M | -1.04M | -1.04M | -1.04M |
| Issuance of Common Stock | 388.40K | 68.30K | 265.60K | 270.90K | 305.30K |
| Repurchase of Common Stock | -- | 0.00 | -533.00K | -533.00K | -533.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -267.30K | -217.30K | -- | -- | -- |
| Cash from Financing | -171.40K | -1.19M | -1.31M | -1.30M | -1.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.30M | -75.21M | -80.65M | -62.54M | -1.60M |